Feb. 6, 2003 (New Orleans) — In a head-to-head study comparing intra-articular hylan GF-20 injection (Synvisc) to corticosteroid injection for knee osteoarthritis, "there was no difference in outcome ...
Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...
The existing viscosupplements on the market in Japan require a greater number of injections than Synvisc, and may offer a much shorter duration of pain relief. Synvisc, the first non-Japanese ...
To earn CME related to this news article, click here. March 5, 2009 — The US Food and Drug Administration (FDA) has approved budesonide plus formoterol fumarate dihydrate inhalation aerosol for the ...
Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, FL. — Six-month intra-articular injections of hylan G-F 20 (Synvisc) administered without regard to ...
Synvisc-One (hylan G-F 20, from Genzyme), has been FDAapproved for the relief of pain associated with osteoarthritis (OA) of the kneein patients who have failed to respond adequately to ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted marketing approval to Genzyme Corp. for its Synvisc-One product indicated for the relief of ...
I am 47 years old. I have severe osteoarthritis in both knees and I still run 40 miles per week. My knees constantly ache even though I do physical therapy, home exercises and get regular Synvisc ...
BOSTON -- It was about a week ago that Mike Lowell approached manager Terry Francona and said it might be time for another injection of Synvisc to help his surgically repaired right hip. Lowell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results